VGN-R13
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VGN-R13, covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS [EARLY_Phase 1]